Dexlansoprazole
Dexlansoprazole is a proton pump inhibitor (acid-blocking medicine) used to heal erosive esophagitis, maintain healing of erosive esophagitis, and treat heartburn from GERD.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 16 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Dexlansoprazole: Patient Information Guide
A plain-language walkthrough of Dexlansoprazole — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Dexlansoprazole delayed-release capsules are a proton pump inhibitor (PPI) approved for the following uses in patients 12 years of age and older:
- Healing erosive esophagitis (EE): Dexilant and dexlansoprazole delayed-release capsules are approved to heal all grades of EE — acid-caused damage to the esophagus lining — for up to 8 weeks.
- Maintaining healed EE and relieving heartburn: Dexilant and dexlansoprazole delayed-release capsules are approved to keep the esophagus healed and control heartburn — up to 6 months in adults and up to 16 weeks in adolescents 12–17 years old.
- Symptomatic non-erosive GERD: Dexilant and dexlansoprazole delayed-release capsules are approved to treat heartburn in people with GERD who do not have visible esophageal damage, for 4 weeks.
⚙️How it works▾
Dexlansoprazole belongs to a class of medicines called proton pump inhibitors (PPIs). It works by directly blocking the H+/K+-ATPase enzyme — the "proton pump" — on the acid-secreting cells of the stomach lining. This pump is the final step in producing stomach acid, so blocking it cuts acid production at the source and allows irritated or damaged esophageal tissue to heal.
The capsule uses a dual delayed-release design, meaning it releases the medicine in two separate waves — one within the first 1–2 hours and a second wave 4–5 hours after you take it. This keeps acid suppression going longer throughout the day.
💊How it's taken▾
Dexlansoprazole delayed-release capsules are taken once daily by mouth. They can be taken with or without food. The capsule should be swallowed whole; do not chew it.
- If swallowing is difficult, open the capsule and sprinkle the intact granules or pellets onto a tablespoon of applesauce and swallow right away — do not chew the pellets.
- The contents can also be mixed with water and administered by oral syringe or nasogastric (NG) tube following specific preparation steps.
- If you miss a dose, take it as soon as you remember — unless your next scheduled dose is coming up soon, in which case skip the missed dose. Never take two doses at once.
The duration of treatment differs by condition — from 4 weeks for non-erosive GERD to up to 6 months for maintaining healed EE. Follow your prescriber's instructions exactly.
🤒Side effects — in detail▾
The most common side effects reported in clinical trials include:
- Diarrhea
- Abdominal (stomach) pain
- Nausea
- Upper respiratory tract infection
- Vomiting
- Flatulence (gas)
- Headache, abdominal pain, and sore throat (more common in adolescents 12–17)
More serious reactions — including severe allergic reactions, kidney inflammation, very low magnesium levels (causing muscle cramps or irregular heartbeat), severe skin reactions, and a lupus-like condition — require prompt medical attention. Call your doctor right away if you notice any of these.
⚠️Warnings & precautions▾
- Serious allergic reactions and kidney inflammation: Dexlansoprazole can, rarely, cause acute tubulointerstitial nephritis (sudden kidney inflammation) or severe allergic reactions including anaphylaxis. Stop taking it and seek care immediately if you have trouble breathing, facial swelling, or signs of kidney trouble.
- Severe skin reactions: Rare but life-threatening skin conditions like Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have been reported. Stop the medicine at the first sign of blistering, peeling, or a widespread rash.
- Low magnesium (hypomagnesemia): Long-term use can deplete magnesium, potentially causing muscle cramps, irregular heartbeat, or seizures. Monitoring may be needed, especially if you also take digoxin or diuretics.
- Lupus-like reactions: Both skin-only and systemic lupus erythematosus have been reported with PPI use. If you develop a new rash or joint pain, tell your doctor.
- Bone fractures: Long-term or high-dose PPI use is linked to a higher risk of hip, wrist, and spine fractures. Use the lowest dose for the shortest time needed.
- C. difficile infection: PPI use may increase the risk of a serious gut infection called Clostridioides (formerly Clostridium) difficile, especially in hospitalized patients. Persistent diarrhea should be evaluated.
- Vitamin B12 deficiency: Using acid-suppressing medicines for more than 3 years may reduce absorption of vitamin B12.
- Gastric malignancy: In adults, feeling better on this medicine does not rule out stomach cancer. If symptoms return quickly or don't respond well, further evaluation may be needed.
- Not for children under 2 years old: Animal studies showed heart valve thickening; dexlansoprazole is not recommended in pediatric patients under age 2.
🔀What it interacts with▾
Dexlansoprazole can interact with several medications — always tell your prescriber and pharmacist everything you take:
- Rilpivirine-containing HIV products — absolutely contraindicated; combining these reduces HIV treatment effectiveness and is not safe.
- Nelfinavir (HIV medicine) — avoid combining; dexlansoprazole reduces its absorption and effectiveness.
- Warfarin (blood thinner) — can increase warfarin's effect, raising bleeding risk; INR needs to be monitored.
- Methotrexate — dexlansoprazole may raise methotrexate levels in the blood, increasing the risk of toxicity, particularly at high doses used for cancer.
- Digoxin (heart medicine) — dexlansoprazole may increase digoxin blood levels; monitoring and possible dose adjustment needed.
- Tacrolimus (transplant anti-rejection drug) — blood levels may rise, especially in poor metabolizers of CYP2C19; close monitoring required.
- St. John's Wort and rifampin — these can lower dexlansoprazole levels significantly; avoid combining.
- Iron salts, antifungals (ketoconazole, itraconazole), and some cancer drugs — lower stomach acid from dexlansoprazole can reduce absorption of these medications.
- Neuroendocrine tumor tests and secretin stimulation tests — dexlansoprazole can cause false positive results; stop the medicine at least 14–30 days before these tests as directed.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not take dexlansoprazole if you are allergic to any of its ingredients or if you take rilpivirine-containing HIV medications.
- Tell your doctor if you have moderate or severe liver disease — a dose adjustment may be needed, and the medicine is not recommended in severe liver impairment.
- Tell your doctor if you are pregnant. Animal studies suggest possible effects on fetal bone development; discuss the risks and benefits with your healthcare provider.
- If you are breastfeeding, talk to your doctor — it is not known whether dexlansoprazole passes into human breast milk.
- This medicine is approved for ages 12 and older only. It should not be used in children under 2 years of age.
- Older adults (65+) can take dexlansoprazole; no overall differences in safety or effectiveness were observed compared to younger adults, but report any new symptoms to your doctor.
- Tell your doctor if you take digoxin, diuretics, tacrolimus, methotrexate, or any HIV medications before starting dexlansoprazole.
- If you have a history of low magnesium, low calcium, or osteoporosis, make sure your doctor knows before starting long-term therapy.
🚑If you take too much▾
There are no reports of significant harm from dexlansoprazole overdose. High doses used in studies did not cause death, though serious high blood pressure has been reported with above-recommended doses. If you think you or someone else has taken too much, call Poison Control at 1-800-222-1222 right away. Treatment is supportive, and dexlansoprazole is not removed by dialysis.
📡Pharmacodynamics — effects in the body▾
Dexlansoprazole significantly raises the pH (reduces the acidity) inside the stomach. In a clinical study, a once-daily dose kept stomach acid suppressed for about 17 hours out of every 24 — longer than comparator lansoprazole at 14 hours. With long-term use, the body responds to reduced acid by producing more of a hormone called gastrin; this returns to normal levels within about a month of stopping the medicine. At doses up to five times the maximum recommended amount, dexlansoprazole does not cause any clinically meaningful changes to heart rhythm.
🔬Pharmacokinetics — how your body processes it▾
Dexlansoprazole uses a dual delayed-release design that produces two absorption peaks — one within 1–2 hours after taking it, and a second 4–5 hours later — providing prolonged acid suppression from a single daily dose. The medicine is extensively broken down in the liver, mainly by enzymes CYP2C19 and CYP3A4, into inactive metabolites; none of the original drug is excreted unchanged in urine. Its half-life (the time for half the drug to leave the body) is approximately 1–2 hours. About half the absorbed drug is excreted in urine and half in feces, and food intake can modestly affect how much is absorbed, though the capsule can be taken with or without food.
📦How to store it▾
Store at 20 to 25°C (68 to 77°F); excursions permitted to 15 to 30°C (59 to 86°F) .
📄 Written from Dexlansoprazole’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Dexlansoprazole
153 supplements and herbal products have documented interactions with Dexlansoprazole in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 3
- Moderate · 101
- Minor · 49
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Dexlansoprazole has been associated with lower levels of 9 nutrients in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
- Higher significance · 5
- Moderate · 1
- Unrated · 3
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Dexlansoprazole — the kind of thing our pharmacy team would talk through with you at the counter.
Can I take this medicine with food, or do I need to take it on an empty stomach? ▾
I have trouble swallowing capsules. Is there another way to take this? ▾
How long will I need to take this? ▾
Are there any medicines I really should not take alongside this? ▾
What side effects should I actually worry about versus just put up with? ▾
Is it safe to take this for a long time? ▾
Is Dexlansoprazole available over the counter? ▾
When was Dexlansoprazole first available? ▾
Who makes Dexlansoprazole? ▾
💬 Answers drafted from Dexlansoprazole’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Dexlansoprazole comes
Dexlansoprazole is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Delayed-release capsule
How this form is used
- Dexilant is approved to heal all grades of erosive esophagitis (EE) in patients 12 and older
- Dexilant is approved to maintain healed EE and relieve heartburn in patients 12 and older
- Dexilant is approved to treat heartburn from symptomatic non-erosive GERD in patients 12 and older
- Dexlansoprazole delayed-release capsules carry the same three approvals: healing EE, maintaining healed EE with heartburn relief, and treating symptomatic non-erosive GERD in patients 12 and older
- Take once daily by mouth, with or without food; swallow the capsule whole and do not chew
- If you have trouble swallowing, open the capsule and sprinkle the intact pellets or granules onto one tablespoon of applesauce — swallow immediately and do not chew
- The capsule contents can also be mixed with water and given by oral syringe or nasogastric (NG) tube — follow the detailed steps in the prescribing information
- If you miss a dose, take it as soon as you remember unless your next dose is due soon — never take two doses at once
📊 Dexlansoprazole across the U.S. market
How Dexlansoprazole appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (16) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Dexlansoprazole is used
A general measure of how commonly Dexlansoprazole is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Dexlansoprazole is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Dexlansoprazole prescribed? Of the 1,597 medications we measure, Dexlansoprazole ranks #448 by Medicaid prescriptions — more than 72% of them.
Utilization by Dexlansoprazole product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
dexlansoprazole 60 MG Delayed Release Oral Capsule Most dispensed
Summed across the 8 of 34 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 833213
dexlansoprazole 30 MG Delayed Release Oral Capsule
Summed across the 4 of 22 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 833204
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Dexlansoprazole, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 12 of 56 listed Dexlansoprazole NDCs with Medicaid activity.
🔍 Compare Dexlansoprazole products
A representative set of FDA-listed product records for Dexlansoprazole — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Delayed-release capsule | ||||
| 30 mg | Oral | A-S Medication Solutions | NDA AUTHORIZED GENERIC | Find on DailyMed ↗ |
| 60 mg | Oral | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 60 mg | Oral | A-S Medication Solutions × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 60 mg | Oral | A-S Medication Solutions | NDA | Find on DailyMed ↗ |
| 30 mg | Oral | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 60 mg | Oral | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 30 mg | Oral | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 60 mg | Oral | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 30 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC | ANDA | View NDC → |
| 30 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 60 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 60 mg | Oral | Cardinal Health | NDA | View NDC → |
| 60 mg | Oral | Cardinal Health 107, LLC | NDA | View NDC → |
| 30 mg | Oral | Golden State Medical Supply, Inc. × 3 listings | ANDA | View NDC → |
| 60 mg | Oral | Golden State Medical Supply, Inc. × 3 listings | ANDA | View NDC → |
| 30 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 60 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 30 mg | Oral | Par Health USA, LLC | ANDA | View NDC → |
| 60 mg | Oral | Par Health USA, LLC | ANDA | View NDC → |
| 30 mg | Oral | Par Pharmaceutical, Inc. | ANDA | View NDC → |
| 60 mg | Oral | Par Pharmaceutical, Inc. × 2 listings | ANDA | View NDC → |
| 60 mg | Oral | Remedyrepack Inc. | ANDA | View NDC → |
| 30 mg | — | Takeda GmbH, Oranienburg | DRUG FOR FURTHER PROCESSING | View NDC → |
| 60 mg | — | Takeda GmbH, Oranienburg | DRUG FOR FURTHER PROCESSING | View NDC → |
| 30 mg | Oral | Takeda Pharmaceuticals America, Inc. × 3 listings | NDA | View NDC → |
| 60 mg | Oral | Takeda Pharmaceuticals America, Inc. × 3 listings | NDA | View NDC → |
| 30 mg | Oral | Twi Pharmaceuticals, Inc. × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 30 mg | Oral | Twi Pharmaceuticals, Inc. | ANDA | View NDC → |
| 60 mg | Oral | Twi Pharmaceuticals, Inc. × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 60 mg | Oral | Twi Pharmaceuticals, Inc. | ANDA | View NDC → |
| 30 mg | Oral | Upsher-Smith Laboratories, LLC | ANDA | View NDC → |
| 60 mg | Oral | Upsher-Smith Laboratories, LLC | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Amino Chemicals Ltd | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Chromo Laboratories India Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Dr.Reddy's laboratories Limited × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Hetero Drugs Limited × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Jubilant Biosys limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Matrix Pharmacorp Private Limited | BULK INGREDIENT | View NDC → |
| 10 kg/10 kg | — | Metrochem Api Private Limited | BULK INGREDIENT | View NDC → |
| 25 kg/25 kg | — | Metrochem API Private Limited × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | MSN Laboratories Private Limited × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | MSN Life Sciences Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Optimus Drugs Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
Showing 63 of 63 products — FDA National Drug Code Directory. See every product, package size and price: browse all 63 Dexlansoprazole NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Dexlansoprazole — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Dexlansoprazole in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Dexlansoprazole went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 816346 1 dose form · 2 strengths
-
Dose form (SCDF) Delayed Release Oral Capsule RxCUI 833203In current FDA listings
Look up RxCUI 816346 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Dexlansoprazole is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 3 more on the FDA NDC directory.
RxNorm drug class
Dexlansoprazole belongs to the Proton Pump Inhibitor class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 16 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Twi Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.